BEVERLY, Mass. - Inogen reported total revenue of $85.1 million for the first quarter of 2026, a 3.4% increase compared to the prior-year period, ahead of the company’s expectations.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the ...
(1) Stockholder engagement and proxy defense costs include third-party advisory, legal, and other professional fees. (2) Income tax impact of adjustments represents the tax impact related to the ...
Zacks Investment Research on MSN
Here's why you should retain Inogen stock in your portfolio for now
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen ...
Zacks Investment Research on MSN
Inogen (INGN) reports Q1 loss, beats revenue estimates
Inogen (INGN) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.25 per share a year ago. These figures are adjusted ...
An update from Inogen ( (INGN) ) is now available.
Welcome to Inogen's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 6, 2024. I would now like to turn the call over ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results